These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21267559)

  • 21. Cardiac Amyloidosis for the Primary Care Provider: A Practical Review to Promote Earlier Recognition of Disease.
    Zhang KW; Vallabhaneni S; Alvarez-Cardona JA; Krone RJ; Mitchell JD; Lenihan DJ
    Am J Med; 2021 May; 134(5):587-595. PubMed ID: 33444590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone scintigram in cardiac amyloidosis: a case report.
    Ali A; Turner DA; Rosenbush SW; Fordham EW
    Clin Nucl Med; 1981 Mar; 6(3):105-8. PubMed ID: 6257442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The non-invasive biopsy: molecular imaging for the detection of cardiac involvement in systemic disease.
    Bengel FM
    Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1299-300. PubMed ID: 25104807
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiac amyloidosis: a review of a series of cases.
    Povar-Echeverría M; Auquilla-Clavijo PE; Povar-Marco BJ; Moreno-Esteban EM; Figueras-Villalba MP
    Arch Cardiol Mex; 2020; 90(3):259-265. PubMed ID: 32952176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of cardiovascular magnetic resonance in suspected cardiac amyloidosis.
    Fernandez AB; Leitner J; Okolo J; Atalay MK; Goldstein L; Abbott JD
    J Cardiovasc Med (Hagerstown); 2012 Sep; 13(9):590-2. PubMed ID: 22306785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Negative myocardial technetium-99m pyrophosphate scintigraphy in amyloid heart disease associated with type AA systemic amyloidosis.
    Leinonen H; Tötterman KJ; Korppi-Tommola T; Korhola O
    Am J Cardiol; 1984 Jan; 53(2):380-1. PubMed ID: 6320621
    [No Abstract]   [Full Text] [Related]  

  • 27. Echocardiographic and pathologic findings of wild-type transthyretin senile systemic amyloidosis developed in early 50s.
    Yoshioka G; Watanabe N; Koita H; Asada Y; Ashikaga K; Kuriyama N; Shibata Y
    J Echocardiogr; 2018 Dec; 16(4):187-188. PubMed ID: 29700757
    [No Abstract]   [Full Text] [Related]  

  • 28. Current Concepts of Cardiac Amyloidosis: Diagnosis, Clinical Management, and the Need for Collaboration.
    Ritts AJ; Cornell RF; Swiger K; Singh J; Goodman S; Lenihan DJ
    Heart Fail Clin; 2017 Apr; 13(2):409-416. PubMed ID: 28279425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis.
    Austin BA; Tang WH; Rodriguez ER; Tan C; Flamm SD; Taylor DO; Starling RC; Desai MY
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1369-77. PubMed ID: 20083070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection.
    Lee VW; Caldarone AG; Falk RH; Rubinow A; Cohen AS
    Radiology; 1983 Jul; 148(1):239-42. PubMed ID: 6304810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloidosis of the heart and respiratory system.
    Van Geluwe F; Dymarkowski S; Crevits I; De Wever W; Bogaert J
    Eur Radiol; 2006 Oct; 16(10):2358-65. PubMed ID: 16703313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging: CMR imaging in patients with cardiac amyloidosis.
    Mearns BM
    Nat Rev Cardiol; 2014 Mar; 11(3):125. PubMed ID: 24469675
    [No Abstract]   [Full Text] [Related]  

  • 33. Advances in PET-Based Cardiac Amyloid Radiotracers.
    Gallegos C; Miller EJ
    Curr Cardiol Rep; 2020 May; 22(6):40. PubMed ID: 32430600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic work-up of cardiac amyloidosis.
    Onsea K; Wisanto E; Van Lier D; Van de Werf F
    Acta Cardiol; 2010 Aug; 65(4):487-8. PubMed ID: 20821947
    [No Abstract]   [Full Text] [Related]  

  • 35. A cardiac diagnostic.
    N Y State J Med; 1961 Apr; 61():1337-8 passim. PubMed ID: 14447253
    [No Abstract]   [Full Text] [Related]  

  • 36. Recent advances in diagnosis and treatment of cardiac amyloidosis.
    Izumiya Y; Takashio S; Oda S; Yamashita Y; Tsujita K
    J Cardiol; 2018 Feb; 71(2):135-143. PubMed ID: 29113705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Case 8. Cardiac amyloidosis in magnetic resonance imaging.].
    Casares Santiago M; Pastrana MA; Cavero MA
    Radiologia; 2009; 51(2):214; discussion 221-2. PubMed ID: 19282013
    [No Abstract]   [Full Text] [Related]  

  • 38. Echocardiographic and electrocardiographic presentations of patients with endomyocardial biopsy-proven cardiac amyloidosis.
    Roslan A; Kamsani SH; Nay TW; Tan KL; Hakim N; Tan AM; Megat Samsudim WN; Tan KL; Jauhari AT; Krishnan M; Leong D; Supramaniam T; Tan LK; Nuruddin AA
    Med J Malaysia; 2018 Dec; 73(6):388-392. PubMed ID: 30647209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.
    Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
    Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging in systemic amyloidosis.
    Sachchithanantham S; Wechalekar AD
    Br Med Bull; 2013; 107():41-56. PubMed ID: 23896486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.